Read-Gene S.A. (WSE:RDG)
5.00
0.00 (0.00%)
Last updated: Sep 3, 2026, 1:50 PM CET
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 58.36 million as of September 4, 2026. Its market cap has decreased by -20.16% in one year.
Market Cap
58.36M
Enterprise Value
61.31M
Revenue
16.66M
Ranking
n/a
PE Ratio
113.87
Stock Price
5.00
ChartMarket Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 58.36M, an increase of 83.33%. That is a compound annual growth rate of 3.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 58.95M | -8.42% |
| Dec 30, 2025 | 64.37M | 10.08% |
| Dec 30, 2024 | 58.48M | -14.48% |
| Dec 29, 2023 | 68.38M | 124.81% |
| Dec 30, 2022 | 30.42M | -8.19% |
| Dec 29, 2021 | 33.13M | 8.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.71B |
| NEUCA | 3.53B |
| Synektik Spólka Akcyjna | 2.79B |
| Voxel | 1.38B |
| NanoGroup | 104.01M |
| Urteste | 65.77M |
| Genomtec | 55.66M |
| Milton Essex Spólka Akcyjna | 45.82M |